0
Your cart

Your cart is empty

Browse All Departments
  • All Departments
Price
  • R2,500 - R5,000 (1)
  • -
Status
Brand

Showing 1 - 1 of 1 matches in All Departments

Drug Safety Data: How To Analyze, Summarize And Interpret To Determine Risk (Paperback): Michael J Klepper, Barton Cobert Drug Safety Data: How To Analyze, Summarize And Interpret To Determine Risk (Paperback)
Michael J Klepper, Barton Cobert
R2,109 Discovery Miles 21 090 Out of stock

Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk was selected for The First Clinical Research Bookshelf - Essential reading for clinical research professionals by the Journal of Clinical Research Best Practices. Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk provides drug safety/pharmacovogilance professionals, pharmaceutical and clinical research scientists, statisticians, programmers, medical writers, and technicians with an accessible, practical framework for the analysis, summary and interpretation of drug safety data. The only guide of its kind, Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk is an invaluable reference for pre- and post-marketing risk assessment. With decades of pharmaceutical research and drug safety expertise, authors Dr. Klepper and Dr. Cobert discuss how quality planning, safety training, and data standardization result in significant cost, time, and resource savings. Through illustrative, step-by-step instruction, Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk is the definitive guide to drug safety data analysis and reporting. Key features include: * Step-by-step instruction on how to analyze, summarize and interpret safety data for mandatory governmental safety reports * Pragmatic tips...and mistakes to avoid * Simple explanations of what safety data are collected, and what the data mean * Practical approaches to determining a drug effect and understanding its clinical significance * Guidance for determining risk throughout the lifecycle of a drug, biologic or nutraceutical * Examples of user-friendly data displays that enhance safety signal identification * Ways to improve data quality and reduce the time, resources and costs involved in mandatory safety reporting * Relevant material for the required training of drug safety/pharmacovigilance professionals * SPECIAL FEATURE: Actual examples of an Integrated Analysis of Safety (IAS) -used in the preparation of the Integrated Summary of Safety (ISS) and the Summary of Clinical Safety (SCS) reports -, and the Periodic Safety Update Report (PSUR)

Free Delivery
Pinterest Twitter Facebook Google+
You may like...
Ultrasound in Rheumatology - A Practical…
Qasim Akram, Subhasis Basu Hardcover R3,182 Discovery Miles 31 820
Essential Imaging in Rheumatology
John O'Neill Hardcover R5,614 Discovery Miles 56 140
Haunted Reno
Janice Oberding Paperback R568 R526 Discovery Miles 5 260
Iterative Learning Control for Flexible…
Tingting Meng, Wei He Hardcover R4,198 Discovery Miles 41 980
World War II at Camp Hale - Blazing a…
David R Witte Paperback R651 Discovery Miles 6 510
Efficient Modeling and Control of…
Javad Mohammadpour, Karolos M Grigoriadis Hardcover R4,621 Discovery Miles 46 210
Remarkable Women of Stockton
Mary Jo Gohlke Paperback R536 Discovery Miles 5 360
Theatres in Los Angeles
Suzanne Tarbell Cooper, Amy Ronnebeck Hall, … Paperback R620 Discovery Miles 6 200
Hidden Figures - The Untold Story of the…
Margot Lee Shetterly Paperback  (1)
R323 R256 Discovery Miles 2 560
Ghosts and Legends of Nevada's Highway…
Janice Oberding Paperback R492 Discovery Miles 4 920

 

Partners